Epidemiology of Idiopathic Pulmonary Fibrosis in Northern Italy. PLoS One. 2016;11(2):e0147072. \[[PMC free article: PMC4740484](/pmc/articles/PMC4740484/)\] \[[PubMed: 26841042](https://pubmed.ncbi.nlm.nih.gov/26841042)\] 17. Mostafaei S, Sayad B, Azar MEF, Doroudian M, Hadifar S, Behrouzi A, Riahi P, Hussen BM, Bayat B, Nahand JS, Moghoofei M. The role of viral and bacterial infections in the pathogenesis of IPF: a systematic review and meta-analysis. Respir Res. 2021 Feb 12;22(1):53. \[[PMC free article: PMC7880524](/pmc/articles/PMC7880524/)\] \[[PubMed: 33579274](https://pubmed.ncbi.nlm.nih.gov/33579274)\] 18. Oldham JM, Collard HR. Comorbid Conditions in Idiopathic Pulmonary Fibrosis: Recognition and Management. Front Med (Lausanne). 2017;4:123. \[[PMC free article: PMC5539138](/pmc/articles/PMC5539138/)\] \[[PubMed: 28824912](https://pubmed.ncbi.nlm.nih.gov/28824912)\] 19. Papadogiannis G, Bouloukaki I, Mermigkis C, Michelakis S, Ermidou C, Mauroudi E, Moniaki V, Tzanakis N, Antoniou KM, Schiza SE. Patients with idiopathic pulmonary fibrosis with and without obstructive sleep apnea: differences in clinical characteristics, clinical outcomes, and the effect of PAP treatment. J Clin Sleep Med. 2021 Mar 01;17(3):533-544. \[[PMC free article: PMC7927327](/pmc/articles/PMC7927327/)\] \[[PubMed: 33108270](https://pubmed.ncbi.nlm.nih.gov/33108270)\] 20. Kimura M, Taniguchi H, Kondoh Y, Kimura T, Kataoka K, Nishiyama O, Aso H, Sakamoto K, Hasegawa Y. Pulmonary hypertension as a prognostic indicator at the initial evaluation in idiopathic pulmonary fibrosis. Respiration. 2013;85(6):456-63. \[[PubMed: 23257350](https://pubmed.ncbi.nlm.nih.gov/23257350)\] 21. Izbicki G, Ben-Dor I, Shitrit D, Bendayan D, Aldrich TK, Kornowski R, Kramer MR. The prevalence of coronary artery disease in end-stage pulmonary disease: is pulmonary fibrosis a risk factor? Respir Med. 2009 Sep;103(9):1346-9. \[[PubMed: 19362458](https://pubmed.ncbi.nlm.nih.gov/19362458)\] 22. Lee JH, Lee HH, Park HJ, Kim S, Kim YJ, Lee JS, Kim HC. Venous thromboembolism in patients with idiopathic pulmonary fibrosis, based on nationwide claim data. Ther Adv Respir Dis. 2023 Jan-Dec;17:17534666231155772. \[[PMC free article: PMC9972056](/pmc/articles/PMC9972056/)\] \[[PubMed: 36846942](https://pubmed.ncbi.nlm.nih.gov/36846942)\] 23. Lee JS, Ryu JH, Elicker BM, Lydell CP, Jones KD, Wolters PJ, King TE, Collard HR. Gastroesophageal reflux therapy is associated with longer survival in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2011 Dec 15;184(12):1390-4. \[[PMC free article: PMC3262030](/pmc/articles/PMC3262030/)\] \[[PubMed: 21700909](https://pubmed.ncbi.nlm.nih.gov/21700909)\] 24. Kreuter M, Wuyts W, Renzoni E, Koschel D, Maher TM, Kolb M, Weycker D, Spagnolo P, Kirchgaessler KU, Herth FJ, Costabel U. Antacid therapy and disease outcomes in idiopathic pulmonary fibrosis: a pooled analysis. Lancet Respir Med. 2016 May;4(5):381-9. \[[PubMed: 27050871](https://pubmed.ncbi.nlm.nih.gov/27050871)\] 25. Linden PA, Gilbert RJ, Yeap BY, Boyle K, Deykin A, Jaklitsch MT, Sugarbaker DJ, Bueno R. Laparoscopic fundoplication in patients with end-stage lung disease awaiting transplantation. J Thorac Cardiovasc Surg. 2006 Feb;131(2):438-46. \[[PubMed: 16434276](https://pubmed.ncbi.nlm.nih.gov/16434276)\] 26. Oldham JM, Kumar D, Lee C, Patel SB, Takahashi-Manns S, Demchuk C, Strek